Another week, another rollercoaster in the fast-moving world of cannabis.
At Cannabis Wealth, we’ve been following all the big industry and policy news in a week which has seen some important developments..
Meanwhile, over at Cannabis Health, our in depth coverage of the ongoing growth of cannabis as a medical and wellness product continues
Been busy and want to get caught up in a hurry?
Here are the six things you need to read to stay in the loop this week.
Tiger King cannabis?
A new high profile figure is reportedly set to enter the cannabis industry: Joe Exotic.
The self-proclaimed ‘Tiger King’ shot to infamy after a Netflix series lifted the lid on his colourful lifestyle and criminal activities.
Exotic – whose legal name is Joseph Allen Maldonado-Passage – is currently serving a 22-year prison sentence for trying to hire a hitman to kill animal rights campaigner Carole Baskin and a range of animal cruelty offences.
Read more here.
Epilepsy treatment free in Ireland
MGC Pharmaceuticals has scored a major win as the Irish government confirms its epilepsy treatment will be covered by the country’s health service.
CannEpil, an experimental drug derived from cannabis, is a high CBD, low THC treatment for drug resistant epilepsy.
Ireland has had a limited medical cannabis programme since 2019 but took the significant step in January of this year of incorporating into the national the health service (the HSE).
You can read the full story here.
End of CBD in China?
A Canadian CBD firm is pulling out of China, the latest sign the giant market is being closed to the industry.
The country of 1.4 billion people had a growing cosmetic CBD market which was able to flourish thanks to a 2015 decision to allow the compound to be used in consumer applications.
But Beijing authorities have reversed their decision and it could be curtains for China’s CBD sector.
Read more here.
Push for reform
Industry experts have welcomed a Government taskforce call for reform to UK medical cannabis regulations.
The Taskforce on Innovation, Growth and Regulatory Reform (TIGRR) has made two key recommendations that, if implemented, could be a major boost for the UK’s medical cannabis industry.
TIGRR was set up to review the nation’s existing legislation and seek out new opportunities in the country’s “new-found regulatory freedom” post-Brexit.
Read more here.
Medical cannabis and Tourette’s
In 2018, Jim Finch was involved in a serious car accident which left him severely injured and battling a number of complex neurological conditions.
Overnight he went from being a young, fit and healthy dad to suffering constant motor and vocal tics and coprolalia, as a result of his Tourette’s syndrome.
Read about his experiences with medical cannabis here.
‘Stop the suffering’
Campaigner Hannah Deacon is calling on the Prime Minister to “stop the suffering” of children who need NHS access to medical cannabis.
Three years on since her son was granted access to medical cannabis in the UK, Hannah Deacon will return to Downing Street today in the hopes of meeting with the Prime Minister again.
On 19 June 2018, Alfie Dingley became the first patient in the UK to receive a permanent license which meant he could be prescribed medicinal cannabis on the NHS.
Read more here.
[activecampaign form=31]
